Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

(2013) Mohamed Bassiouny et al.   Circulation-Arrhythmia and Electrophysiology

Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation

(2013) Hirosuke Yamaji et al.   CLINICAL DRUG INVESTIGATION

Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation

(2013) C. Eitel et al.   EUROPACE

Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation

(2013) WILLIAM MADDOX et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter

(2013) Daniel W. Kaiser et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay

(2013) Kimitake Imamura et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

(2012) Jeff S. Healey et al.   CIRCULATION

Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2012) Kenichi Kaseno et al.   CIRCULATION JOURNAL

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

(2012) H. Calkins et al.   EUROPACE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation

(2012) Jin-Seok Kim et al.   HEART RHYTHM

A comparison of bleeding complications post-ablation between warfarin and dabigatran

(2012) David Snipelisky et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2012) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation

(2012) TAKAMITSU NIN et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

(2009) Riccardo Cappato et al.   Circulation-Arrhythmia and Electrophysiology

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complications of Catheter Ablation for Atrial Fibrillation: Incidence and Predictors

(2008) DAVID D. SPRAGG et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY